Trials / Completed
CompletedNCT01214512
Performance Evaluation of the Micromedic CD24 in Vitro Diagnostic Assay
Performance Evaluation of the Micromedic CD24 Western Blot and ELISA in Vitro Diagnostic Assay
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 229 (actual)
- Sponsor
- Meir Medical Center · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
This study is aimed to evaluate the performance of the Micromedic CD24 assay in identifying colorectal adenoma using Western blot and ELISA assays. These assays are designed to detect CD24 protein in peripheral blood leukocytes (PBL). Elevated levels of CD24 may be indicative of colorectal adenoma (inclusive of optically detectable early adenoma to late adenoma, and cancer).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | blood-sample based diagnostic assay | A blood sample will be used in a Western blot and ELISA assay to determine CD24 levels |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2010-10-05
- Last updated
- 2013-03-12
Locations
2 sites across 1 country: Israel
Source: ClinicalTrials.gov record NCT01214512. Inclusion in this directory is not an endorsement.